HealthLeaders-InterStudy and Fingertip Formulary find that pharmacy directors expect health plans to cover Collegium's COL-003 and King Pharmaceutical's Remoxy over other emerging agents for chronic pain. According to the new report entitled Formulary Advantages in Analgesics for Chronic Pain Therapies: How Will Emerging Reformulations and Fixed-Dose Combinations Fare Among U.S...
More...
More...